微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2023-03-31 | 51.81% | 10.85% | 3.02% | 72/159 | 52.21% | 迪哲医药 | 97.73% | 行业排名> |
| 2022-12-31 | 50.29% | 21.36% | 9.89% | 82/159 | 52.8% | 百利天恒 | 97.99% | 行业排名> |
| 2022-09-30 | 45.77% | 11.78% | 1% | 88/159 | 7.21% | 百利天恒 | 98.92% | 行业排名> |
| 2022-06-30 | 45.31% | 14.91% | -3.06% | 87/159 | 21.28% | 迈威生物 | 98.93% | 行业排名> |
| 2022-03-31 | 46.74% | 22.7% | 12.8% | 81/159 | 53.71% | 迈威生物 | 99.59% | 行业排名> |
| 2021-12-31 | 41.44% | -3.91% | 1.21% | 96/159 | 54.28% | 迈威生物 | 99.8% | 行业排名> |
| 2021-09-30 | 40.94% | -11.08% | 3.82% | 90/159 | 46.48% | 迈威生物 | 99.46% | 行业排名> |
| 2021-06-30 | 39.43% | -17.42% | 3.52% | 103/159 | 46.84% | 迈威生物 | 99.75% | 行业排名> |
| 2021-03-31 | 38.09% | -20.18% | -11.67% | 93/159 | 53.7% | 迈威生物 | 99.67% | 行业排名> |
| 2020-12-31 | 43.13% | 0.1% | -6.33% | 101/159 | -140.7% | 迈威生物 | 99.44% | 行业排名> |
| 2020-09-30 | 46.04% | 2.52% | -3.58% | 85/159 | 56.3% | 迈威生物 | 98.57% | 行业排名> |
| 2020-06-30 | 47.75% | 3.35% | 0.05% | 84/159 | 54.37% | 首药控股 | 99.93% | 行业排名> |
| 2020-03-31 | 47.73% | 0.16% | 10.78% | 74/159 | 55.4% | 艾力斯 | 99.41% | 行业排名> |
| 2019-12-31 | 43.08% | -2.1% | -4.08% | 93/159 | -1177.54% | 艾力斯 | 98.7% | 行业排名> |
| 2019-09-30 | 44.91% | -1.77% | -2.79% | 73/159 | 55.15% | 艾力斯 | 99.4% | 行业排名> |
| 2019-06-30 | 46.2% | 3.29% | -3.04% | 72/159 | 55.14% | 首药控股 | 99.94% | 行业排名> |
| 2019-03-31 | 47.65% | 6.2% | 8.29% | 64/159 | 51.2% | 泽璟制药 | 99.96% | 行业排名> |
| 2018-12-31 | 44% | 9.03% | -3.75% | 88/159 | -198.79% | 微芯生物 | 95.14% | 行业排名> |
| 2018-09-30 | 45.72% | 15.35% | 2.21% | 66/159 | 53.93% | 多瑞医药 | 95.59% | 行业排名> |
| 2018-06-30 | 44.73% | 10.87% | -0.31% | 67/159 | 53.49% | 微芯生物 | 95.81% | 行业排名> |
| 2018-03-31 | 44.87% | 10.6% | 11.17% | 67/159 | 54.18% | 微芯生物 | 96.09% | 行业排名> |
| 2017-12-31 | 40.36% | 5.65% | 1.83% | 81/159 | 52.25% | 微芯生物 | 96.11% | 行业排名> |
| 2017-09-30 | 39.63% | -0.35% | -1.76% | 63/159 | 48.93% | 微芯生物 | 95.5% | 行业排名> |
| 2017-06-30 | 40.35% | 11.38% | -0.55% | 64/159 | 47.58% | 微芯生物 | 96.27% | 行业排名> |
| 2017-03-31 | 40.57% | 17.18% | 6.19% | 50/159 | 46.55% | 贝达药业 | 95.47% | 行业排名> |
| 2016-12-31 | 38.2% | -21.81% | -3.95% | 74/159 | 48.07% | 贝达药业 | 95.51% | 行业排名> |
| 2016-09-30 | 39.77% | -17.15% | 9.8% | 47/159 | 45.46% | 贝达药业 | 95.54% | 行业排名> |
| 2016-06-30 | 36.22% | -16.92% | 4.64% | 61/159 | 46.17% | 贝达药业 | 95.74% | 行业排名> |
| 2016-03-31 | 34.62% | -22.88% | -29.15% | 53/159 | 42.99% | 退市金泰 | 96.19% | 行业排名> |
| 2015-12-31 | 48.86% | 13.22% | 1.78% | 47/159 | 45.93% | 贝达药业 | 95.81% | 行业排名> |
| 2015-09-30 | 48.01% | 16.17% | 10.1% | 34/159 | 44.18% | 退市金泰 | 95.93% | 行业排名> |
| 2015-06-30 | 43.6% | 15.53% | -2.86% | 45/159 | 44.93% | 贝达药业 | 95.58% | 行业排名> |
| 2015-03-31 | 44.89% | 30.48% | 4.02% | 34/159 | 42.29% | 贝达药业 | 95.89% | 行业排名> |
| 2014-12-31 | 43.15% | 5.12% | 4.42% | 48/159 | 43.06% | -- | -- | 行业排名> |
| 2014-09-30 | 41.33% | 2.8% | 9.5% | 35/159 | 41.01% | -- | -- | 行业排名> |
| 2014-06-30 | 37.74% | -10.58% | 9.71% | 37/159 | 40.3% | -- | -- | 行业排名> |
| 2014-03-31 | 34.4% | -18.8% | -16.2% | 39/159 | 39.72% | -- | -- | 行业排名> |
| 2013-12-31 | 41.05% | 15.73% | 2.11% | 46/159 | 41.86% | -- | -- | 行业排名> |
| 2013-09-30 | 40.2% | 13.25% | -4.75% | 28/159 | 38.23% | -- | -- | 行业排名> |
| 2013-06-30 | 42.21% | 12.69% | -0.38% | 27/159 | 38.52% | 舒泰神 | 94.16% | 行业排名> |
| 2013-03-31 | 42.37% | 3.32% | 19.44% | 24/159 | 37.21% | -- | -- | 行业排名> |